Entity
AstraZeneca
AstraZeneca is a British-Swedish multinational pharmaceutical company that researches, develops, manufactures, and sells prescription medicines primarily for oncology, cardiovascular, and immunology diseases.
Why it’s in the news: It is in the news due to concerns and setbacks surrounding its proposed $400 billion megamerger with Bristol-Myers Squibb.
Latest on AstraZeneca
- STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
- How investors killed AstraZeneca’s $400bn megadeal
- Deal or No Deal, AstraZeneca Stock Is a Bargain
- AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough
- AstraZeneca investors raise concerns over mega-merger talks
- STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
- 13F: True Freedom Investing Llc holds Astrazeneca ($7M)
- 13F: Deutsche Bank Ag\ holds Astrazeneca ($2.4B)
- 13F: Martin Investment Management Llc holds Astrazeneca ($24M)
Connections
13 entities linked to AstraZeneca across the news graph.
Also connected to (13)
Martin Investment Management LlcSTAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and moreSTAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefitDeal or No Deal, AstraZeneca Stock Is a BargainAstraZeneca and Bristol-Myers: when Big Pharma isn’t big enoughAn AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’Health Care Roundup: Market TalkTrue Freedom Investing LlcDeutsche Bank Ag\Bristol Myers SquibbBig PharmaBristol-MyersMAS